{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:10:11Z","timestamp":1791382211988,"version":"4.3.3"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.neuroscience.2021.12.035","type":"journal-article","created":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T10:40:06Z","timestamp":1640947206000},"page":"206-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Circ_0001665 Contributes to the Occurrence of Vestibular Schwannoma via Targeting miR-302a-3p\/Adam9\/EGFR Signaling Pathway"],"prefix":"10.1016","volume":"490","author":[{"given":"Lihua","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianman","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biyu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaopeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2021.12.035_b0005","first-page":"192","article-title":"Vestibular schwannoma","volume":"148","author":"Araiza Navarrete","year":"2012","journal-title":"Gac Med Mex"},{"key":"10.1016\/j.neuroscience.2021.12.035_b0010","first-page":"1856","article-title":"ADAM9: A novel player in vestibular schwannoma pathogenesis","volume":"19","author":"Breun","year":"2020","journal-title":"Oncol Lett"},{"issue":"29","key":"10.1016\/j.neuroscience.2021.12.035_b0015","doi-asserted-by":"crossref","first-page":"47365","DOI":"10.18632\/oncotarget.17648","article-title":"ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis","volume":"8","author":"Chiu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.neuroscience.2021.12.035_b0020","doi-asserted-by":"crossref","unstructured":"Chou CW, Huang YK, Kuo TT, Liu JP, Sher YP (2020), An overview of ADAM9: structure, activation, and regulation in human diseases. Int J Mol Sci 21.","DOI":"10.3390\/ijms21207790"},{"key":"10.1016\/j.neuroscience.2021.12.035_b0025","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s00115-019-0721-7","article-title":"Update on diagnostics and microsurgical treatment of vestibular schwannoma","volume":"90","author":"Ebner","year":"2019","journal-title":"Der Nervenarzt"},{"issue":"5","key":"10.1016\/j.neuroscience.2021.12.035_b0030","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3171\/2011.6.JNS11131","article-title":"The molecular biology and novel treatments of vestibular schwannomas","volume":"115","author":"Fong","year":"2011","journal-title":"J Neurosurg"},{"key":"10.1016\/j.neuroscience.2021.12.035_b0035","first-page":"457","article-title":"[CircRNA as a new field in human disease research]","volume":"43","author":"Gao","year":"2018","journal-title":"Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China J Chin Mater Med"},{"key":"10.1016\/j.neuroscience.2021.12.035_b0040","doi-asserted-by":"crossref","unstructured":"Kong P, Yu Y, Wang L, Dou YQ, Zhang XH, Cui Y, Wang HY, Yong YT, et al. (2019), circ-Sirt1 controls NF-\u03baB activation via sequence-specific interaction and enhancement of SIRT1 expression by binding to miR-132\/212 in vascular smooth muscle cells. Nucleic Acids Res 47:3580\u20133593.","DOI":"10.1093\/nar\/gkz141"},{"issue":"3","key":"10.1016\/j.neuroscience.2021.12.035_b0045","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/08941939.2012.728682","article-title":"Overexpression of ADAM9 promotes colon cancer cells invasion","volume":"26","author":"Li","year":"2013","journal-title":"J Invest Surg"},{"key":"10.1016\/j.neuroscience.2021.12.035_b0050","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/s41419-019-2089-9","article-title":"CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression","volume":"10","author":"Liu","year":"2019","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.neuroscience.2021.12.035_b0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbrc.2018.05.114","article-title":"circRNA_0084043 promote malignant melanoma progression via miR-153-3p\/Snail axis","volume":"502","author":"Luan","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.neuroscience.2021.12.035_b0060","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1002\/jcp.27039","article-title":"RELA\/NEAT1\/miR-302a-3p\/RELA feedback loop modulates pancreatic ductal adenocarcinoma cell proliferation and migration","volume":"234","author":"Luo","year":"2019","journal-title":"J Cell Physiol"},{"issue":"1","key":"10.1016\/j.neuroscience.2021.12.035_b0065","doi-asserted-by":"crossref","first-page":"318","DOI":"10.18632\/aging.102617","article-title":"Circ-EPB41L5 regulates the host gene EPB41L5 via sponging miR-19a to repress glioblastoma tumorigenesis","volume":"12","author":"Lv","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.neuroscience.2021.12.035_b0070","doi-asserted-by":"crossref","first-page":"104522","DOI":"10.1016\/j.yexmp.2020.104522","article-title":"MiR-302a-3p aggravates myocardial ischemia-reperfusion injury by suppressing mitophagy via targeting FOXO3","volume":"117","author":"Lv","year":"2020","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.neuroscience.2021.12.035_b0075","doi-asserted-by":"crossref","unstructured":"Maier W, Hassepa\u00df F, Aschendorff A, Laszig R (2012), [Vestibular schwannoma. Part 2: therapy, prognosis, and rehabilitation]. Hno 60:927-935; quiz 936-927.","DOI":"10.1007\/s00106-012-2534-x"},{"key":"10.1016\/j.neuroscience.2021.12.035_b0080","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41419-018-0291-9","article-title":"LINC01016 promotes the malignant phenotype of endometrial cancer cells by regulating the miR-302a-3p\/miR-3130-3p\/NFYA\/SATB1 axis","volume":"9","author":"Pan","year":"2018","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.neuroscience.2021.12.035_b0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1517\/14728222.2011.648617","article-title":"Targeting the EGFR signaling pathway in cancer therapy","volume":"16","author":"Seshacharyulu","year":"2012","journal-title":"Expert Opin Therap Targets"},{"key":"10.1016\/j.neuroscience.2021.12.035_b0090","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41419-020-02745-x","article-title":"Circ-ADAM9 targeting PTEN and ATG7 promotes autophagy and apoptosis of diabetic endothelial progenitor cells by sponging mir-20a-5p","volume":"11","author":"Tian","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.neuroscience.2021.12.035_b0095","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.3892\/or.2017.5460","article-title":"ADAM9 functions as a promoter of gastric cancer growth which is negatively and post-transcriptionally regulated by miR-126","volume":"37","author":"Wang","year":"2017","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.neuroscience.2021.12.035_b0100","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1080\/21691401.2019.1671856","article-title":"Circular RNA ADAM9 facilitates the malignant behaviours of pancreatic cancer by sponging miR-217 and upregulating PRSS3 expression","volume":"47","author":"Xing","year":"2019","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"3","key":"10.1016\/j.neuroscience.2021.12.035_b0105","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s13402-020-00503-x","article-title":"CircRNA BIRC6 promotes non-small cell lung cancer cell progression by sponging microRNA-145","volume":"43","author":"Yang","year":"2020","journal-title":"Cell Oncol (Dordrecht)"},{"key":"10.1016\/j.neuroscience.2021.12.035_b0110","doi-asserted-by":"crossref","first-page":"8175","DOI":"10.2147\/OTT.S167162","article-title":"MicroRNA-302a-3p suppresses hepatocellular carcinoma progression by inhibiting proliferation and invasion","volume":"11","author":"Ye","year":"2018","journal-title":"OncoTargets Ther"},{"issue":"1","key":"10.1016\/j.neuroscience.2021.12.035_b0115","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-018-0827-8","article-title":"Circular RNAs function as ceRNAs to regulate and control human cancer progression","volume":"17","author":"Zhong","year":"2018","journal-title":"Mol Cancer"},{"key":"10.1016\/j.neuroscience.2021.12.035_b0120","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/s41419-019-2127-7","article-title":"CircRNA-ENO1 promoted glycolysis and tumor progression in lung adenocarcinoma through upregulating its host gene ENO1","volume":"10","author":"Zhou","year":"2019","journal-title":"Cell Death Dis"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452221006667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452221006667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:12:55Z","timestamp":1759680775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452221006667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":24,"alternative-id":["S0306452221006667"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2021.12.035","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circ_0001665 Contributes to the Occurrence of Vestibular Schwannoma via Targeting miR-302a-3p\/Adam9\/EGFR Signaling Pathway","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2021.12.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 IBRO. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}